Literature DB >> 24652794

Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice.

Rafael Kramann1, Mari Tanaka2, Benjamin D Humphreys3.   

Abstract

AKI predicts the future development of CKD, and one proposed mechanism for this epidemiologic link is loss of peritubular capillaries triggering chronic hypoxia. A precise definition of changes in peritubular perfusion would help test this hypothesis by more accurately correlating these changes with future loss of kidney function. Here, we have adapted and validated a fluorescence microangiography approach for use with mice to visualize, analyze, and quantitate peritubular capillary dynamics after AKI. A novel software-based approach enabled rapid and automated quantitation of capillary number, individual area, and perimeter. After validating perfusion in mice with genetically labeled endothelia, we compared peritubular capillary number and size after moderate AKI, characterized by complete renal recovery, and after severe AKI, characterized by development of interstitial fibrosis and CKD. Eight weeks after severe AKI, we measured a 40%±7.4% reduction in peritubular capillary number (P<0.05) and a 36%±4% decrease in individual capillary cross-sectional area (P<0.001) for a 62%±2.2% reduction in total peritubular perfusion (P<0.01). Whereas total peritubular perfusion and number of capillaries did not change, we detected a significant change of single capillary size following moderate AKI. The loss of peritubular capillary density and caliber at week 8 closely correlated with severity of kidney injury at day 1, suggesting irreparable microvascular damage. These findings emphasize a direct link between severity of acute injury and future loss of peritubular perfusion, demonstrate that reduced capillary caliber is an unappreciated long-term consequence of AKI, and offer a new quantitative imaging tool for understanding how AKI leads to future CKD in mouse models.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  acute renal failure; chronic kidney disease; vascular disease

Mesh:

Year:  2014        PMID: 24652794      PMCID: PMC4147987          DOI: 10.1681/ASN.2013101121

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  31 in total

1.  Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.

Authors:  Y J Choi; S Chakraborty; V Nguyen; C Nguyen; B K Kim; S I Shim; W N Suki; L D Truong
Journal:  Hum Pathol       Date:  2000-12       Impact factor: 3.466

2.  CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.

Authors:  Derek P DiRocco; John Bisi; Patrick Roberts; Jay Strum; Kwok-Kin Wong; Norman Sharpless; Benjamin D Humphreys
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-11

3.  Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function.

Authors:  D P Basile; D Donohoe; K Roethe; J L Osborn
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

4.  Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

Authors:  Duk-Hee Kang; Alison H Joly; Se-Woong Oh; Christian Hugo; Dontscho Kerjaschki; Katherine L Gordon; Marilda Mazzali; J Ashley Jefferson; Jeremy Hughes; Kirsten M Madsen; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

Review 5.  Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.

Authors:  Yujiro Kida; Bie Nga Tchao; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2013-03-10       Impact factor: 3.714

6.  Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha.

Authors:  Hai-Tao Yuan; Xiao-Zhong Li; Jolanta E Pitera; David A Long; Adrian S Woolf
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 7.  Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy.

Authors:  David P Basile
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-01       Impact factor: 2.894

8.  PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors.

Authors:  Christina I Baumann; Alexis S Bailey; Weiming Li; Michael J Ferkowicz; Mervin C Yoder; William H Fleming
Journal:  Blood       Date:  2004-05-04       Impact factor: 22.113

9.  Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.

Authors:  Carlos Gonzalez-Quesada; Michele Cavalera; Anna Biernacka; Ping Kong; Dong-Wook Lee; Amit Saxena; Olga Frunza; Marcin Dobaczewski; Arti Shinde; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2013-09-30       Impact factor: 17.367

10.  Cardiac microvascular rarefaction in hyperthyroidism-induced left ventricle dysfunction.

Authors:  Felipe Freitas; Vanessa Estato; Vinícius Frias Carvalho; Rafael Carvalho Torres; Marcos Adriano Lessa; Eduardo Tibiriçá
Journal:  Microcirculation       Date:  2013-10       Impact factor: 2.628

View more
  57 in total

1.  Cisplatin nephrotoxicity as a model of chronic kidney disease.

Authors:  Mingjun Shi; Kathryn L McMillan; Junxia Wu; Nancy Gillings; Brianna Flores; Orson W Moe; Ming Chang Hu
Journal:  Lab Invest       Date:  2018-06-01       Impact factor: 5.662

2.  Ultrasound super-resolution imaging provides a noninvasive assessment of renal microvasculature changes during mouse acute kidney injury.

Authors:  Qiyang Chen; Jaesok Yu; Brittney M Rush; Sean D Stocker; Roderick J Tan; Kang Kim
Journal:  Kidney Int       Date:  2020-03-03       Impact factor: 10.612

Review 3.  Advances in predictive in vitro models of drug-induced nephrotoxicity.

Authors:  Joanne Y-C Soo; Jitske Jansen; Rosalinde Masereeuw; Melissa H Little
Journal:  Nat Rev Nephrol       Date:  2018-06       Impact factor: 28.314

4.  Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Authors:  Mingjun Shi; Brianna Flores; Peng Li; Nancy Gillings; Kathryn L McMillan; Jianfeng Ye; Lily Jun-Shen Huang; Sachdev S Sidhu; Yong-Ping Zhong; Maria T Grompe; Philip R Streeter; Orson W Moe; Ming Chang Hu
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

Review 5.  Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

Authors:  Manjeri A Venkatachalam; Joel M Weinberg; Wilhelm Kriz; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2015-03-25       Impact factor: 10.121

6.  Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels.

Authors:  Shulin Li; Yanping Wang; Lu Chen; Zhuojun Wang; Guodong Liu; Bangjie Zuo; Caixia Liu; Dong Sun
Journal:  J Mol Med (Berl)       Date:  2019-03-28       Impact factor: 4.599

7.  Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.

Authors:  David P Basile; Joseph V Bonventre; Ravindra Mehta; Masaomi Nangaku; Robert Unwin; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-30       Impact factor: 10.121

Review 8.  Renal fibrosis: Primacy of the proximal tubule.

Authors:  Leslie S Gewin
Journal:  Matrix Biol       Date:  2018-02-06       Impact factor: 11.583

9.  Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks.

Authors:  Paul Pang; Molly Abbott; Steven L Chang; Malyun Abdi; Nikita Chauhan; Murti Mistri; Joshua Ghofrani; Quynh-Anh Fucci; Colleen Walker; Corey Leonardi; Samuel Grady; Arvin Halim; Ryan Hoffman; Tzongshi Lu; Huixia Cao; Stefan G Tullius; Sayeed Malek; Sanjaya Kumar; Graeme Steele; Adam Kibel; Benjamin S Freedman; Sushrut S Waikar; Andrew M Siedlecki
Journal:  Kidney Int       Date:  2016-09-29       Impact factor: 10.612

Review 10.  Acute kidney injury and chronic kidney disease: From the laboratory to the clinic.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nephrol Ther       Date:  2016-03-10       Impact factor: 0.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.